Jed Kaminetsky, MD

View Locations

About Me

Conditions and Treatments

low testosterone, prostate disease, benign prostatic hyperplasia, erectile dysfunction, vasectomy
Learn more about conditions we treat at NYU Langone:
Male Urinary Dysfunction, Erectile Dysfunction

Credentials

Positions
  • Clinical Assistant Professor, Department of Urology
Board Certifications
  • American Board of Urology - Urology, 1992
Education and Training
  • Residency, NYU Medical Center, Urology, 1990
  • Residency, Montefiore Medical Center, Surgery (Gen), 1986
  • MD from New York University, 1984
Departments

Is this your profile?

Edit profile

Is this your profile?

Edit profile

Locations and Appointments

View Insurance Plans Accepted
  • Aetna
    • Aetna HMO
    • Aetna Indemnity
    • Aetna Medicare
    • Aetna POS
    • Aetna PPO/EPO
  • Cigna
    • Cigna EPO/POS
    • Cigna PPO
  • Empire Blue Cross Blue Shield
    • Empire Blue Cross Blue Shield EPO
    • Empire Blue Cross Blue Shield HMO
    • Empire Blue Cross Blue Shield Indemnity
    • Empire Blue Cross Blue Shield MediBlue
    • Empire Blue Cross Blue Shield POS
    • Empire Blue Cross Blue Shield PPO
    • Empire Blue Cross Blue Shield Pathways, Enhanced
  • GHI
    • GHI CBP
  • HIP
    • HIP Access I
    • HIP Access II
    • HIP Child Health
    • HIP EPO/PPO
    • HIP HMO
    • HIP Medicare
    • HIP POS
  • Humana
    • Humana Medicare
  • Local 1199
    • Local 1199 PPO
  • MagnaCare
    • MagnaCare PPO
  • MultiPlan/PHCS
    • MultiPlan/PHCS PPO
  • NYS
    • NYS Empire Plan
  • Oxford
    • Oxford Freedom
    • Oxford Liberty
    • Oxford Medicare
  • PHP
    • PHP
  • UHC
    • UnitedHealthcare EPO
    • UnitedHealthcare HMO
    • UnitedHealthcare Medicare
    • UnitedHealthcare POS
    • UnitedHealthcare PPO
    • UnitedHealthcare Top Tier
  • UPN
    • UPN Elite
Jed Kaminetsky M.D.

215 Lexington Avenue, 20th Floor
New York, NY 10016

Phone

212-686-9015

View Map

Research Academic Contact

Phone

212-686-9015

Publications

  • International prostate symptom score assessment following palladium-103 line source for prostate brachytherapy implants [Meeting Abstract]

    Prestidge, B; Stock, R; Kaminetsky, J; Moran, B

    Brachytherapy. 2018 July -; Conference:(2018):S90-S91

  • Efficacy and Safety of SER120 Nasal Spray in Nocturia Patients Pooled Analysis of 2 Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials

    Kaminetsky, Jed; Fein, Seymour; Dmochowski, Roger; MacDiarmid, Scott; Abrams, Steven; Cheng, Maria; Wein, Alan

    Journal of urology. 2018 Apr 12;

  • Efficacy and Safety of SER120 Nasal Spray in Patients with Nocturia: Pooled Analysis of 2 Randomized, Double-Blind, Placebo Controlled, Phase 3 Trials

    Kaminetsky, J; Fein, S; Dmochowski, R; MacDiarmid, S; Abrams, S; Cheng, M; Wein, A

    Journal of urology. 2018; (),(2018):

Read All Publications (25)